Chemo plus radiation for older adults with pancreatic cancer
Part of Cancer clinical trials.
This trial tests whether combining chemotherapy and radiation can safely treat pancreatic cancer in patients aged 70–85 who have not had surgery or prior cancer treatment. The goal is to find a better approach for older adults who might not be able to have standard surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 70 and 85 years old
- You have locally advanced pancreatic cancer that cannot be removed by surgery (or you can't have surgery for health reasons)
- You have not had any previous cancer treatment like chemo, radiation, or targeted therapy
- Your blood counts and liver/kidney function are within certain safe limits
- You are generally active and able to do daily tasks (ECOG score 0 or 1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares adding radiation to chemotherapy versus chemotherapy alone after surgery for pancreatic cancer. It is for people whose cancer had certain high-risk features found during surgery, and who have not yet started additional treatment.
This trial tests a new chemotherapy combination (HR070803 plus two other drugs) given after surgery to see if it prevents pancreatic cancer from coming back better than the current standard treatment.
This trial tests whether giving chemotherapy before surgery can help adults aged 70 or older who have pancreatic cancer in the head of the pancreas. The goal is to see if this approach makes surgery more effective and improves outcomes.
This trial compares two different chemotherapy combinations, each paired with immunotherapy and radiation, as the first treatment for locally advanced pancreatic cancer. It aims to see which combination works better.
This trial tests a combination of targeted radiation and two oral drugs (defactinib and avutometinib) for people with advanced pancreatic cancer that hasn't spread to distant organs. It may be an option if you've already had at least 2 months of chemo and your cancer is still locally advanced or borderline resectable.
This trial tests a combination of two chemotherapy drugs (AG) plus an immunotherapy (cadonilimab) and a short course of radiation for people with locally advanced pancreatic cancer that hasn't been treated yet. The goal is to see if this approach helps shrink or control the tumor.
Hear when a new Unresectable Locally Advanced Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.